Clobetasol propionate and Crohn's disease - a phase IV clinical study of FDA data

Summary:

Crohn's disease is reported as a side effect among people who take Clobetasol propionate (clobetasol propionate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Meloxicam, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Crohn's disease when taking Clobetasol propionate. It is created by eHealthMe based on reports of 10,373 people who have side effects when taking Clobetasol propionate from the FDA, and is updated regularly.

What is Clobetasol propionate?

Clobetasol propionate has active ingredients of clobetasol propionate. It is often used in psoriasis. eHealthMe is studying from 10,661 Clobetasol propionate users. Check the latest studies of Clobetasol propionate.

What is Crohn's disease?

Crohn's disease (a condition that causes inflammation of the gastrointestinal tract) is found to be associated with 1,352 drugs and 2,075 conditions by eHealthMe. Check the latest studies of Crohn's disease.



On Aug, 07, 2026

10,373 people reported to have side effects when taking Clobetasol propionate.
Among them, 51 people (0.49%) have Crohn's disease.

Could Clobetasol propionate cause Crohn's disease?

Among these 51 people:

How long have people been on Clobetasol propionate when they have Crohn's disease? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Crohn's disease when taking Clobetasol propionate? *

  • female: 69.05 %
  • male: 30.95 %

What is the age of people who have Crohn's disease when taking Clobetasol propionate? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 16.22 %
  • 20-29: 5.41 %
  • 30-39: 8.11 %
  • 40-49: 0.0 %
  • 50-59: 16.22 %
  • 60+: 54.05 %

What are other drugs people take besides Clobetasol propionate? *

  1. Meloxicam: 14 people, 27.45%
  2. Simponi: 10 people, 19.61%
  3. Botox: 10 people, 19.61%
  4. Vitamin D3: 10 people, 19.61%
  5. Magnesium Oxide: 10 people, 19.61%
  6. Elidel: 9 people, 17.65%
  7. Omeprazole Magnesium: 9 people, 17.65%
  8. Prolia: 9 people, 17.65%
  9. Remicade: 8 people, 15.69%
  10. Quetiapine Fumarate: 8 people, 15.69%

What are other side effects people have besides Crohn's disease? *

  1. High Blood Pressure: 21 people, 41.18%
  2. Joint Pain: 17 people, 33.33%
  3. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 27.45%
  4. Inflammatory Bowel Disease: 13 people, 25.49%
  5. Hypotension (abnormally low blood pressure): 12 people, 23.53%
  6. Urticaria (rash of round, red welts on the skin that itch intensely): 11 people, 21.57%
  7. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 11 people, 21.57%
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints): 11 people, 21.57%
  9. Seborrhoeic Keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest): 11 people, 21.57%
  10. Enthesopathy (disorder of entheses (bone attachments)): 10 people, 19.61%

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 11 people, 21.57%
  2. High Blood Pressure: 8 people, 15.69%
  3. Diarrhea: 8 people, 15.69%
  4. Abdominal Pain Upper: 7 people, 13.73%
  5. High Blood Cholesterol: 6 people, 11.76%
  6. Metastases To Bone (cancer spreads to bone): 4 people, 7.84%
  7. Diabetes: 2 people, 3.92%
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 3.92%
  9. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 1.96%
  10. Birth Control: 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Clobetasol propionate and have Crohn's disease?

- Check whether Crohn's disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clobetasol propionate:

Crohn's disease treatments and more:

How severe was Crohn's disease and when was it recovered:

Expand to all the drugs that have ingredients of clobetasol propionate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clobetasol propionate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Crohn's disease:

Browse all the conditions that are associated with Crohn's disease:


How the study uses the data?

The study uses data from the FDA. It is based on clobetasol propionate (the active ingredients of Clobetasol propionate) and Clobetasol propionate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: